Efficacy of sorafenib plus transcatheter arterial chemoembolization in treating hepatocellular carcinoma with portal vein tumor thrombosis: A meta-analysis

This meta-analysis aimed to evaluate the efficacy of sorafenib plus transcatheter arterial chemoembolization (TACE) in treating hepato-cellular carcinoma (HCC) with portal vein tumor thrombosis (PVTT). Twelve randomized controlled trials published until 28th Sep 2022 were finally included. Of the to...

詳細記述

書誌詳細

出版年:	Acta Pharmaceutica
主要な著者:	Xu Li, Chen Shanshan, Cao Haijun, Feng Zemin, Yang Chao
フォーマット:	論文
言語:	英語
出版事項:	Sciendo 2024-09-01
主題:	hepatocellular carcinoma portal vein tumor thrombosis transcatheter arterial chemoembolization sorafenib
オンライン･アクセス:	https://doi.org/10.2478/acph-2024-0019